The markets opened higher with the Dow rising 26 points to 17,789 as crude oil prices rebounded. Nasdaq added 8 points to 4,894.
On the upside
China granted regulatory clearance to Cytori Therapeutics' (Nasdaq: CYTX) exclusive licensee Lorem Vascular to market and sell the Cytori Celution System.
Bristol-Myers (NYSE: BMY) entered an exclusive strategic collaboration with uniQure (Nasdaq: QURE) to develop gene therapies for cardiovascular diseases.
Shares of Voltari (Nasdaq: VLTC) continued climbing.
On the downside
Regulatory approval of the merger between Hudson City Bancorp (Nasdaq: HCBK) and M&T Bank has been delayed.
Wunderlich analyst Irene Haas downgraded Magnum Hunter Resources (NYSE: MHR) from a Buy rating to a Hold rating.
Profit taking weighed down shares of Nymox Pharmaceutical (Nasdaq: NYMX).
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE while decliners barely edged out advancers by a slim margin on Nasdaq. The broader S&P 500 rose 3 points to 2070. Bitcoin added $1 to $257.
Higher open as crude oil prices rise
April 06, 2015 at 10:43 AM EDT